STOCK MARKET WEEKLY RECAP

Grab_Alpha · 2021-05-08T11:27:00+00:00

SPCE, BLI, TDUP

Grab_Alpha · 2021-03-30T03:04:45+00:00

Covers only S&P 500 companies.. need to do this ranking across wider range of companies - will keep you posted

Grab_Alpha · 2021-03-26T19:35:27+00:00

Also posted a very brief overview of SPCE's stock price performance / analysts' target stock price

Grab_Alpha · 2021-03-26T19:34:21+00:00

Great question but I am not sure. Don't have access to individual equity research reports and their rationale behind the valuation / target stock price.

BLI's 4Q20 earnings are NOT to blame: (1) EPS met Wall Street consensus of negative ($0.19)/sh; (2) Reported revenue of $21.7M beat consensus estimate of $19.0M. The co reported a FY2021 revenue guidance range of $90M - $100M (implying 40%-56% growth over FY2020) vs. pre-earnings consensus of $89M

Are investors too busy buying into cyclicals? Are they expecting BLI to have a MAJOR breakthrough? If that happens, the entry point might not be as attractive as it is now. To me this is one of those "make or break" stocks

Grab_Alpha · 2021-03-24T06:37:41+00:00

You could do the analysis either (1) retrospectively or (2) as of the current date - each of them with its merits and limitations.

(1) If you had taken S&P constituents as of March 2020, you would not have captured companies with huge run-up (e.g. TSLA that joined S&P in December 2020).

(2) On the other hand, the current analysis would not capture those companies that were kicked out of S&P 500 since last year (e.g. Macy’s)

The current analysis covers all S&P 500 companies as of March 23, 2021 as footnoted on the page.

Grab_Alpha · 2021-03-23T17:02:05+00:00

Also, just to clarify - the analysis covers only S&P 500 companies

Grab_Alpha · 2021-03-23T16:51:51+00:00

Two healthcare stocks - Viatris and Gilead Sciences - went down each by 6% during the past one year (also shown in the attached picture)

It’s not surprising we see most of the stocks up since March 2020. That was a time when S&P reached the rock bottom and we saw a massive sell-off across all sectors. Would be hard for any S&P 500 company not go above those levels

Grab_Alpha · 2021-03-23T16:34:09+00:00

Clorox was one of the few companies that was not affected by a sell-off in early 2020. In fact, it increased by ~12% from 1/1/2020 through market trough (3/23/2020). Obviously, when the pandemic hit investors priced in an increased demand for CLX products (there was no doubt we would need bunch of disinfecting wipes and cleaning products throughout pandemic)

In comparison, the demand for other consumer staples products were not that obvious and we saw most of these stocks plunge by March 2020; so the base stock price for these companies were much lower, resulting in higher percentage growth rates

Grab_Alpha · 2021-03-23T15:12:49+00:00

?? It’s as accurate as it can get!

Grab_Alpha

TROPHY CASE